NCT06962111 Early-Stage Partner in Care Living Alone Plus
| NCT ID | NCT06962111 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arizona State University |
| Condition | Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-03-26 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-03-26 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
EPICLA+ (Early-Stage Partners in Care Living Alone Plus) is a research project designed to assist people with early-stage memory loss who live alone in the community by providing early-stage related education and skill-training sessions, held via Zoom, designed to reduce stress, enhance well-being, manage challenges, and plan for the future. Researchers will gather feedback from individuals about their experience to continue to improve programs for early-stage memory loss.
Eligibility Criteria
Early-stage inclusion criteria 1. Must be at least 60 years of age 2. Must be able to participate in English or Spanish 3. Must be a US resident 4. Must be able to provide consent verbally and in writing (electronically or via mail) 5. Must exhibit at least 2 of 8 changes caused by thinking and memory problems on the AD8 (a reliable and valid 8-item dementia screening tool). 6. The Early-stage individual must have a diagnosis of early-stage ADRD or have a Mini-Mental State Exam (MMSE) score: 1. between 20-26 for those who have completed high school, or 2. between 17-26\*, for those who have not completed high school, or 3. 27 or higher with a confirmed diagnosis of early-stage dementia or MCI. 7. Able to participate in EPIC-LA workshops via zoom Exclusion Criteria: 8. Inability to participate via telephone or online video conferencing service. 9. The participant expresses feelings of not wanting to participate 10. The participant do not have enough time to attend the training, 11. The participant demonstrates lack of skills with using a computer that precludes participation 12. The participant does not have a stable internet connection to connect to the video platform 13. The participant has difficulty hearing or a visual impairment that precludes participation.
Contact & Investigator
Dr. Gomez-Morales
PRINCIPAL INVESTIGATOR
ASU
Frequently Asked Questions
Who can join the NCT06962111 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06962111 currently recruiting?
Yes, NCT06962111 is actively recruiting participants. Contact the research team at agomezm1@asu.edu for enrollment information.
Where is the NCT06962111 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT06962111 clinical trial?
NCT06962111 is sponsored by Arizona State University. The principal investigator is Dr. Gomez-Morales at ASU. The trial plans to enroll 70 participants.